Scadenza: 25 January 2022
Topic:
The new ‘Cancer Diagnostic and Treatment for All’ initiative, and the ‘Genomic for Public Health’ project will help Member States to improve access for individuals and cancer patients and survivors to prevention, diagnosis and treatment of cancer through personalised medicine, by upscaling available innovation (12) in the field of innovative cancer diagnosis and treatment.
Applicants shall target their proposal to one or both of the action subtopics (a, b) described below and indicate that clearly in the proposal.
Sub-topic (a) - - ‘Cancer Diagnostic and Treatment for All’ initiative: It will use the ‘next generation sequencing’ technology for a quick and efficient application of personalised cancer diagnosis and treatment. The action will scale up the already available results in genetic profiling of patients and tumour cells allowing cancer centres to share such cancer profiles with a view to apply the same or similar diagnostic and therapeutic approaches to patients with comparable cancer profiles across the Union.
Sub-topic (b) - ‘Genomic for Public Health’ project: which is expected, to scale up the ‘1+ Million Genome Initiative’ results, to translate them into implementable public health measures to address cancer prevention on the basis of specific individual genetic profiles, which indicates the susceptibility of individuals to develop a certain type of cancer. Therefore, the project will open new perspectives to personalised risk-assessment and targeted cancer prevention.
Programma:
EU4 Health Programme (EU4H)
Ente finanziatore:
EU
Budget complessivo:
EUR 3 000 000 for strand a)
EUR 3 000 000 for strand b)
Duration of the project: between 12 and 36 months, the recommended length of a project is 24 months
Who can participate:
Applications by either a sole applicants or by a consortium are acceptable
Partnership: Not Mandatory
Status:
Closed
Topic:
The new ‘Cancer Diagnostic and Treatment for All’ initiative, and the ‘Genomic for Public Health’ project will help Member States to improve access for individuals and cancer patients and survivors to prevention, diagnosis and treatment of cancer through personalised medicine, by upscaling available innovation (12) in the field of innovative cancer diagnosis and treatment.
Applicants shall target their proposal to one or both of the action subtopics (a, b) described below and indicate that clearly in the proposal.
Sub-topic (a) - - ‘Cancer Diagnostic and Treatment for All’ initiative: It will use the ‘next generation sequencing’ technology for a quick and efficient application of personalised cancer diagnosis and treatment. The action will scale up the already available results in genetic profiling of patients and tumour cells allowing cancer centres to share such cancer profiles with a view to apply the same or similar diagnostic and therapeutic approaches to patients with comparable cancer profiles across the Union.
Sub-topic (b) - ‘Genomic for Public Health’ project: which is expected, to scale up the ‘1+ Million Genome Initiative’ results, to translate them into implementable public health measures to address cancer prevention on the basis of specific individual genetic profiles, which indicates the susceptibility of individuals to develop a certain type of cancer. Therefore, the project will open new perspectives to personalised risk-assessment and targeted cancer prevention.
Who can participate:
Applications by either a sole applicants or by a consortium are acceptable
Programme:
EU4 Health Programme (EU4H)
Consortium: Not required
Status: Open
Total budget:
EUR 3 000 000 for strand a)
EUR 3 000 000 for strand b)
Funding rate:
Notes:
Proposals to be awarded under this topic: Up to two proposals
